
From stem cell and gene therapy advancements to expanded pump-sensor partnerships and new FDA medication approvals, this roundup hits the biggest diabetes breakthroughs in 2025.
read more →
From stem cell and gene therapy advancements to expanded pump-sensor partnerships and new FDA medication approvals, this roundup hits the biggest diabetes breakthroughs in 2025.
read more →
Join us for the inaugural Diabetes Jeopardy! game show event at Diabetes Forum, where experts go head-to-head in a lively competition to recap highlights from the ADA’s Scientific Sessions. Get valuable perspectives on the most significant developments in diabetes. Watch live or online.
read more →
Three big things need to happen for a cure for type 1 diabetes to be successful, and we’ve already crossed one of them off the list. Learn the latest research from three companies at the forefront of discovery, and find out when we think a functional cure will be realized (hint: It may be sooner than you think).
read more →
When diabetes lives with you day-to-day like a stage five clinger, it can be easy to feel like advancements in care aren’t happening at a fast enough pace. But we’re here to tell you, things are happening! Here’s a short list of some of the progress we saw in 2024, including new pumps, new CGMs, and exciting research studies with promising results.
read more →
Vertex Pharmaceuticals is relatively new to the type 1 diabetes space, and they are working hard to understand what it’s like for people to live with T1D so they can develop transformative therapies. They’re currently investigating and advancing cell therapies aimed at treating an underlying cause of type 1 – the absence of insulin-producing cells.
read more →